SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,000 | -13.6% | 652 | -5.1% | 0.00% | 0.0% |
| Q1 2022 | $22,000 | +10.0% | 687 | -1.0% | 0.00% | +33.3% |
| Q4 2021 | $20,000 | +5.3% | 694 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $19,000 | -5.0% | 694 | +5.3% | 0.00% | -25.0% |
| Q2 2021 | $20,000 | +17.6% | 659 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $17,000 | 0.0% | 659 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $17,000 | +21.4% | 659 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $14,000 | -12.5% | 659 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $16,000 | +33.3% | 659 | +2.0% | 0.01% | +20.0% |
| Q1 2020 | $12,000 | -50.0% | 646 | -35.4% | 0.01% | -44.4% |
| Q4 2019 | $24,000 | -11.1% | 1,000 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $27,000 | -18.2% | 1,000 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $33,000 | – | 1,000 | – | 0.01% | – |
| Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |